dc.contributor.author | Shah, Rubina | |
dc.contributor.author | Ali, Faraz M | |
dc.contributor.author | Nixon, Stuart J | |
dc.contributor.author | Ingram, John R | |
dc.contributor.author | Salek, Sam M | |
dc.contributor.author | Finlay, Andrew Y | |
dc.date.accessioned | 2021-09-01T13:15:01Z | |
dc.date.available | 2021-09-01T13:15:01Z | |
dc.date.issued | 2021-05-25 | |
dc.identifier.citation | Shah , R , Ali , F M , Nixon , S J , Ingram , J R , Salek , S M & Finlay , A Y 2021 , ' Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey ' , BMJ Open , vol. 11 , no. 5 , e047680 . https://doi.org/10.1136/bmjopen-2020-047680 | |
dc.identifier.issn | 2044-6055 | |
dc.identifier.other | Jisc: 210cb1adcc604da88f58efb4ff36a516 | |
dc.identifier.other | publisher-id: bmjopen-2020-047680 | |
dc.identifier.uri | http://hdl.handle.net/2299/25028 | |
dc.description.abstract | Objective: This study aimed to measure the impact of COVID-19 on the quality of life (QoL) of survivors and their partners and family members. Design and setting: A prospective cross-sectional global online survey using social media. Participants: Patients with COVID-19 and partners or family members (age ≥18 years). Intervention: Online survey from June to August 2020. Main outcome measure: The EuroQol group five dimensions three level (EQ-5D-3L) to measure the QoL of survivors of COVID-19, and the Family Reported Outcome Measure (FROM-16) to assess the impact on their partner/family member’s QoL. Results: The survey was completed by 735 COVID-19 survivors (mean age=48 years; females=563) at a mean of 12.8 weeks after diagnosis and by 571 partners and 164 family members (n=735; mean age=47 years; females=246) from Europe (50.6%), North America (38.5%) and rest of the world (10.9%). The EQ-5D mean score for COVID-19 survivors was 8.65 (SD=1.9, median=9; range=6–14). 81.1% (596/735) reported pain and discomfort, 79.5% (584/735) problems with usual activities, 68.7% (505/735) anxiety and depression and 56.2% (413/735) problems with mobility. Hospitalised survivors (20.1%, n=148) and survivors with existing health conditions (30.9%, n=227) reported significantly more problems with mobility and usual activities (p | en |
dc.format.extent | 710255 | |
dc.language.iso | eng | |
dc.relation.ispartof | BMJ Open | |
dc.subject | Public health | |
dc.subject | 1506 | |
dc.subject | 2474 | |
dc.subject | 1724 | |
dc.subject | COVID-19 | |
dc.subject | public health | |
dc.subject | infection control | |
dc.title | Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey | en |
dc.contributor.institution | Centre for Health Services and Clinical Research | |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.contributor.institution | Department of Clinical and Pharmaceutical Sciences | |
dc.description.status | Peer reviewed | |
rioxxterms.versionofrecord | 10.1136/bmjopen-2020-047680 | |
rioxxterms.type | Journal Article/Review | |
herts.preservation.rarelyaccessed | true | |